- Report
- August 2024
- 381 Pages
Global
From €4243EUR$4,799USD£3,663GBP
- Report
- August 2025
- 197 Pages
Global
From €3134EUR$3,545USD£2,706GBP
€3483EUR$3,939USD£3,007GBP
- Report
- February 2025
- 200 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- August 2025
- 274 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- May 2025
- 187 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- May 2023
- 375 Pages
Global
From €4736EUR$5,543USD£3,950GBP
- Report
- April 2021
- 377 Pages
Global
From €2826EUR$3,196USD£2,440GBP
€3532EUR$3,995USD£3,049GBP
- Report
- March 2024
- 133 Pages
Global
From €5261EUR$5,950USD£4,542GBP
- Report
- January 2023
- 117 Pages
Global
From €3979EUR$4,500USD£3,435GBP
- Report
- August 2024
- 149 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- November 2023
- 102 Pages
Global
From €1326EUR$1,500USD£1,145GBP
The Vaccine Contract Manufacturing market is a specialized segment of the pharmaceutical industry that focuses on the production of vaccines. Vaccine Contract Manufacturing companies provide services such as process development, analytical testing, and fill-finish services for vaccine production. These companies are typically involved in the production of vaccines from the early stages of development to the final stages of manufacturing. Vaccine Contract Manufacturing companies are also involved in the production of biologics, such as monoclonal antibodies, for use in vaccine production.
Some of the companies in the Vaccine Contract Manufacturing market include Lonza, Catalent, and Thermo Fisher Scientific. Show Less Read more
